Month: March 2021

2026.03.19
Genomtec plans to issue shares. The proceeds will be used to support the M&A process and commercialize projects. The company has concluded an investment agreement with a key shareholder.

2026.02.12
Genomtec lines up technology trials with potential Asian partners during M&A efforts

2025.07.31
Genomtec's Supervisory Board appointed Leroy Huntley to the Company's Management Board

2025.07.14
Genomtec has the consent of its shareholders to make a contribution of assets to its subsidiaries in order to accelerate the project sale process

2025.03.26
Genomtec implements changes in organizational structure to accelerate M&A process

Archive

2021.03.18

Genomtec diagnostic test SARS-CoV-2 Duo Kit (cat. no. GA00B) detects newly identified Breton Variant in France

Company has recently confirmed diagnostic positive performance of its most advanced product, Genomtec® SARS-CoV-2 EvaGreen® RT-LAMP CE-IVD Duo ...
Read

Archive